title: N-methyl-D-aspartate receptor antibody encephalitis: how much treatment is enough?
authors.affiliation: Children's Neurosciences, Kings Health Partners Academic Health Science Centre, Evelina London Children's Hospital at Guy's & St Thomas' NHS Trust, London, UK.
authors.forename: Susan
authors.initials: S
authors.lastname: Byrne
authors.forename: Ming
authors.initials: M
authors.lastname: Lim
mesh_terms: D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000188:drug therapy*; D000906:Antibodies / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D008775:Methylprednisolone / Q000494:pharmacology*
chemical_list: D000893:Anti-Inflammatory Agents; D000906:Antibodies; D007166:Immunosuppressive Agents; D008775:Methylprednisolone; D008727:Methotrexate